LivaNova PLC (NASDAQ:LIVN) is highlighted as one of the Best Undervalued UK Stocks to Buy According to Analysts. Jefferies analyst Matthew Taylor maintains a Buy rating on LIVN with a price target of $79, citing the company’s strong growth potential and expansion in the oxygenator market.

Taylor praises LivaNova’s progress in Vagus Nerve Stimulation therapy for epilepsy, strengthening its position in drug-resistant epilepsy treatment. The company is a global medical technology firm specializing in devices for cardiac surgery and neuromodulation, enhancing its competitive edge in the market.

While LIVN shows investment potential, certain AI stocks may offer greater upside and less downside risk. For undervalued AI stock options with significant benefits from current trends, explore the free report on the best short-term AI stock for a potentially lucrative investment opportunity.

Read more at Yahoo Finance: Jefferies Maintained a Buy Rating on LivaNova PLC (LIVN)